Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014

Diabetes, Obesity and Metabolism

Volumn 19, Issue 11, 2017, Pages 1537-1545

  Zghebi, Salwa S ^a,b   Steinke, Douglas T ^a   Carr, Matthew J ^a   Rutter, Martin K ^a,c   Emsley, Richard A ^d   Ashcroft, Darren M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF TRIPOLI   (Libyan Arab Jamahiriya)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

CPRD; database research, incidence; prevalence; primary care; type 2 diabetes

Indexed keywords

ADOLESCENT; ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; MORTALITY RISK; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SEX DIFFERENCE; SOCIAL ISOLATION; SOCIAL STATUS; TREND STUDY; UNITED KINGDOM; FACTUAL DATABASE; MORTALITY; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; PREVALENCE; PRIMARY HEALTH CARE; SURVIVAL ANALYSIS; UNITED KINGDOM; YOUNG ADULT;

EID: 85021780301     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12964     Document Type: Article

References (36)

1. Onat A, Hergenc G, Uyarel H, Can G, Ozhan H. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. Anatol J Cardiol. 2006;6:314-321.
2. Lin CC, Li CI, Hsiao CY, et al. Time trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007: a population-based study. BMC Public Health. 2013;13:1-10.
3. Ubink-Veltmaat LJ, Bilo HJG, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1). Eur J Epidemiol. 2003;18:793-800.
4. Espelt A, Borrell C, Palencia L, et al. Socioeconomic inequalities in the incidence and prevalence of type 2 diabetes mellitus in Europe. Gac Sanit. 2013;27:494-501.
5. World Health Organization (WHO) Media Centre. Diabetes. [Fact sheet]. 2016. http://www.who.int/mediacentre/factsheets/fs312/en/. Accessed April 29, 2016.
6. Diabetes UK. State of the nation England – Challenges for 2015 and beyond. 2014. https://www.diabetes.org.uk/Documents/About%20Us/What%20we%20say/State%20of%20the%20nation%202014.pdf. Accessed April 15, 2016.
7. Gonzalez ELM, Johansson S, Wallander MA, Rodriguez LAG. Trends in the prevalence and incidence of diabetes in the UK: 1996–2005. J Epidemiol Community Health. 2009;63:332-336.
8. Sharma M, Nazareth I, Petersen I. Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study. BMJ Open. 2016;6:e010210.
9. Evans JMM, Barnett KN, Ogston SA, Morris AD. Increasing prevalence of type 2 diabetes in a Scottish population: effect of increasing incidence or decreasing mortality? Diabetologia. 2007;50:729-732.
10. Harvey JN, Craney L, Kelly D. Estimation of the prevalence of diagnosed diabetes from primary care and secondary care source data: comparison of record linkage with capture-recapture analysis. J Epidemiol Community Health. 2002;56:18-23.
11. Gatling W, Guzder RN, Turnbull JC, Budd S, Mullee MA. The Poole Diabetes Study: how many cases of Type 2 diabetes are diagnosed each year during normal health care in a defined community? Diabetes Res Clin Pract. 2001;53:107-112.
12. Holden SE, Barnett AH, Peters JR, et al. The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obes Metab. 2013;15:844-852.
13. Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44:827-836.
14. Williams T, van Staa T, Puri S, Eaton S. Recent advances in the utility and use of the General Practice Research Database as an example of a UK primary care data resource. Ther Adv Drug Saf. 2012;3:89-99.
15. Department for Communities and Local Government. The English Indices of Deprivation 2010, Crown; 2011. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/6871/1871208.pdf. Accessed August 21, 2013.
16. Lester H, Campbell S. Developing Quality and Outcomes Framework (QOF) indicators and the concept of ‘QOFability’. Qual Prim Care. 2010;18:103-109.
17. Lind M, Garcia-Rodriguez LA, Booth GL, et al. Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study. Diabetologia. 2013;56:2601-2608.
18. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA. Mortality in people with Type 2 diabetes in the UK. Diabet Med. 2006;23:516-521.
19. Tancredi M, Rosengren A, Svensson A-M, et al. Excess mortality among persons with type 2 diabetes. N Engl J Med. 2015;373:1720-1732.
20. Office for National Statistics (ONS). Deaths registered in England and Wales: 2013, 2014. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregistrationsummarytables/2014-07-16. Accessed February 12, 2017.
21. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study. Lancet. 2007;369:750-756.
22. International Diabetes Federation (IDF). IDF Diabetes Atlas. 7th ed; 2015. http://www.diabetesatlas.org/. Accessed February 8, 2017.
23. Newnham A, Ryan R, Khunti K, Majeed A. Prevalence of diagnosed diabetes mellitus in general practice in England and Wales, 1994 to 1998. Health Stat Q. 2002;14:5-13.
24. Office for National Statistics (ONS). Mortality in the United Kingdom, 1983–2013. 2014. http://webarchive.nationalarchives.gov.uk/20160105160709/http://www.ons.gov.uk/ons/rel/mortality-ageing/mortality-in-the-united-kingdom/1983-2013/mortality-in-the-united-kingdom--1983-2013.html. Updated December 11, 2014. Accessed July 7, 2015.
25. Diabetes UK. Facts & figures – Annual diabetes prevalence figures. 2015. https://www.diabetes.org.uk/About_us/What-we-say/Statistics/. Accessed July 7, 2016.
26. Forbes A, Murrells T, Sinclair AJ. Examining factors associated with excess mortality in older people (age ≥ 70 years) with diabetes – a 10-year cohort study of older people with and without diabetes. Diabet Med. 2017;34:387-395.
27. NHS Digital. National Diabetes Audit -2012-2013, Report 2. 2015. http://content.digital.nhs.uk/catalogue/PUB16496. Accessed January 26, 2017.
28. Tate AR, Dungey S, Glew S, Beloff N, Williams R, Williams T. Quality of recording of diabetes in the UK: how does the GP's method of coding clinical data affect incidence estimates? Cross-sectional study using the CPRD database. BMJ Open. 2017;7:e012905.
29. World Health Organization (WHO). Global report on diabetes. 2016. http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf. Accessed February 11, 2017.
30. Health and Social Care Information Centre. Quality and outcomes framework. 2016. http://www.hscic.gov.uk/qof. Accessed July 7, 2016.
31. Holman N, Young B, Gadsby R. What is the current prevalence of diagnosed and yet to be diagnosed diabetes in the UK. Diabet Med. 2014;31:510-511.
32. Calvert M, Shankar A, McManus RJ, Lester H, Freemantle N. Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study. BMJ. 2009;338:b1870.
33. World Health Organization (WHO). Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Abbreviated report of a WHO Consultation, Geneva, Switzerland. 2011. http://www.who.int/diabetes/publications/diagnosis_diabetes2011/en/. Accessed January 23, 2013.
34. Bittner V, Bertolet M, Felix RB, et al. Comprehensive cardiovascular risk factor control improves survival the BARI 2D trial. J Am Coll Cardiol. 2015;66:765-773.
35. Gaede P, Lund-Andersen H, Parving H-H, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580-591.
36. Gaede P, Oellgaard J, Carstensen B, et al. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. Diabetologia. 2016;59:2298-2307.